Denise T. Yu

Kensington, NSW 2052, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

GSH facilitates the binding and inhibitory activity of novel multidrug resistance protein 1 (MRP1) modulators.

GSH facilitates the binding and inhibitory activity of novel multidrug resistance protein 1 (MRP1) modulators.

Journal: The FEBS journal

Published: October 13, 2021

Dual targeting of polyamine synthesis and uptake in diffuse intrinsic pontine gliomas.

Dual targeting of polyamine synthesis and uptake in diffuse intrinsic pontine gliomas.

Journal: Nature communications

Published: November 20, 2019

CCI52 sensitizes tumors to 6-mercaptopurine and inhibits MYCN-amplified tumor growth.

CCI52 sensitizes tumors to 6-mercaptopurine and inhibits MYCN-amplified tumor growth.

Journal: Biochemical pharmacology

Published: November 12, 2019

MRP1 modulators synergize with buthionine sulfoximine to exploit collateral sensitivity and selectively kill MRP1-expressing cancer cells.

MRP1 modulators synergize with buthionine sulfoximine to exploit collateral sensitivity and selectively kill MRP1-expressing cancer cells.

Journal: Biochemical pharmacology

Published: May 10, 2019

Targeting metabolic activity in high-risk neuroblastoma through Monocarboxylate Transporter 1 (MCT1) inhibition.

Targeting metabolic activity in high-risk neuroblastoma through Monocarboxylate Transporter 1 (MCT1) inhibition.

Journal: Oncogene

Published: February 03, 2019

Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma.

Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma.

Journal: Science translational medicine

Published: May 16, 2018

Suppression of the ATP-binding cassette transporter ABCC4 impairs neuroblastoma tumour growth and sensitises to irinotecan in vivo.

Suppression of the ATP-binding cassette transporter ABCC4 impairs neuroblastoma tumour growth and sensitises to irinotecan in vivo.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 19, 2017

Upregulation of LYAR induces neuroblastoma cell proliferation and survival.

Upregulation of LYAR induces neuroblastoma cell proliferation and survival.

Journal: Cell death and differentiation

Published: November 30, 2016

The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugs.

The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugs.

Journal: Oncotarget

Published: June 06, 2016

MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4.

MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4.

Journal: Oncotarget

Published: January 11, 2016

Dipeptidyl peptidase 9 enzymatic activity influences the expression of neonatal metabolic genes.

Dipeptidyl peptidase 9 enzymatic activity influences the expression of neonatal metabolic genes.

Journal: Experimental cell research

Published: December 24, 2015

ABC transporters and neuroblastoma.

ABC transporters and neuroblastoma.

Journal: Advances in cancer research

Published: February 03, 2015

Showing 1-12 of 17

Last Updated: 09/26/2026